Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-19-000642
Filing Date
2019-09-19
Accepted
2019-09-19 09:39:07
Documents
1
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5418
  Complete submission text file 0000904454-19-000642.txt   6742
Mailing Address POSTBUS 5187 NAARDEN P7 1410 AD
Business Address
van Deventer Sander (Reporting) CIK: 0001543084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 191101057

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations